News BB Biotech AG Xetra

Equities

Market Closed - Xetra Other stock markets 11:35:50 2024-07-12 am EDT			5-day change	1st Jan Change
43.3 ^EUR	-0.23%		+4.97%	-4.84%

Apr. 27	Tranche Update on BB Biotech AG?s Equity Buyback Plan announced on April 12, 2022.	CI
Apr. 26	Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps	MT

Edison issues report on BB Biotech (BION)	Jun. 26	EQ
Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis	May. 20	EQ
BB BIOTECH AG: Disclosure of Shareholdings	May. 10	EQ
DD: BB BIOTECH AG: Dr. Thomas von Planta, buy	May. 02	EQ
Tranche Update on BB Biotech AG?s Equity Buyback Plan announced on April 12, 2022.	Apr. 27	CI
Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps	Apr. 26	MT
BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates	Apr. 26	EQ
BB Biotech AG publishes its interim report	Apr. 26	EQ
BB Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
DD: BB BIOTECH AG: Dr. Thomas von Planta, buy	Mar. 26	EQ
DD: BB BIOTECH AG: Dr. Thomas von Planta, buy	Mar. 26	EQ
Ex-dividend day for final dividend	Mar. 24	FA
Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share	Mar. 21	EQ
DD: BB BIOTECH AG: Prof. Dr. Mads Krogsgaard Thomsen, buy	Feb. 21	EQ
BB Biotech's Loss Narrows in FY23; Operating Income Down	Feb. 16	MT
BB Biotech AG publishes its 2023 annual report	Feb. 16	EQ
Investor interest returns – dividend yield remains high for 2024	Feb. 14	EQ
Tranche Update on BB Biotech AG?s Equity Buyback Plan announced on April 12, 2022.	Feb. 14	CI
BB Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 13	CI
BB Biotech Trims FY23 Dividend as Net Loss Narrows	Jan. 19	MT

No results for this search